|
|
||||||||||||||
|
|
|||||||||||||||
a GI Clinic and
Department of Medicine, University of Cape Town and Groote Schuur
Hospital, Cape Town, South Africa, b Department of Medical Microbiology, University
of Cape Town and Red Cross Hospital, Cape Town, South Africa, c Division of Gastroenterology and
Institute of Infections and Immunity, University of Nottingham,
Nottingham, UK
Correspondence to: Dr JA Louw, GI Clinic, E23, Groote Schuur Hospital, Observatory, 7925, Cape Town, South Africa. jalouw{at}curie.uct.ac.za.
Accepted for publication 17 January 2001
BACKGROUND
The
development of clinically significant disease in South Africa is
associated with the vacuolating cytotoxin gene
(vacA) s1 genotype but not with the presence
of the cytotoxin associated gene cagA.
cagA occurs in >95% of South African
isolates and is a variable marker for the entire
cag pathogenicity island (PAI).
AIM
To characterise
the cagPAI in South African isolates and to
investigate if structural variants of this multigene locus were associated with variations in vacA status
and clinical outcome.
PATIENTS AND
METHODS
We studied 109 Helicobacter pylori strains (36 from
patients with peptic ulceration, 26 with gastric adenocarcinoma, and 47 with no pathology other than gastritis) for differences in selected genes of the cagPAI and alleles of
vacA by polymerase chain reaction.
RESULTS
All strains
were cagA+. Sixty five (60%)
strains had an intact contiguous cagPAI;
78% of peptic ulcer isolates, 73% of gastric adenocarcinoma isolates,
but only 40% of gastritis alone isolates (p< 0.01). The entire
cagII region was undetectable in 23% of gastritis alone isolates but in only 8% of peptic ulceration isolates (p<0.05). The vacA signal sequence and mid
region demonstrated a strong relationship between the virulence
associated vacA s1 (p<0.005) and
vacA m1 (p=0.05) alleles and an intact
cagPAI.
CONCLUSION
Although a
complete cagPAI was a feature of most
infected individuals, deletions in the 5' region of this genetic locus
were associated with gastritis alone and with the non-cytotoxic s2/m2 vacA genotype.
This article has been cited by other articles:
![]() |
A. Reyes-Leon, J. C. Atherton, R. H. Argent, J. L. Puente, and J. Torres Heterogeneity in the Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its Association with Diversity in the cagA Gene Infect. Immun., July 1, 2007; 75(7): 3445 - 3454. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mattar, S. B. Marques, M. d. S. Monteiro, A. F. dos Santos, K. Iriya, and F. J. Carrilho Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil J. Med. Microbiol., January 1, 2007; 56(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Argent, Y. Zhang, and J. C. Atherton Simple Method for Determination of the Number of Helicobacter pylori CagA Variable-Region EPIYA Tyrosine Phosphorylation Motifs by PCR J. Clin. Microbiol., February 1, 2005; 43(2): 791 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kauser, A. A. Khan, M. A. Hussain, I. M. Carroll, N. Ahmad, S. Tiwari, Y. Shouche, B. Das, M. Alam, S. M. Ali, et al. The cag Pathogenicity Island of Helicobacter pylori Is Disrupted in the Majority of Patient Isolates from Different Human Populations J. Clin. Microbiol., November 1, 2004; 42(11): 5302 - 5308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ong, K. Moozar, and L. B. Cohen Octreotide in Bronchobiliary Fistula Management Ann. Thorac. Surg., October 1, 2004; 78(4): 1512 - 1513. [Full Text] [PDF] |
||||
![]() |
A Ewart, L Harrison, B Joyner, and A Safe Providing treatment for hepatitis C in an Australian district centre Postgrad. Med. J., March 1, 2004; 80(941): 180 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nilsson, A. Sillen, L. Eriksson, M.-L. Strand, H. Enroth, S. Normark, P. Falk, and L. Engstrand Correlation between cag Pathogenicity Island Composition and Helicobacter pylori-Associated Gastroduodenal Disease Infect. Immun., November 1, 2003; 71(11): 6573 - 6581. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |